Cassaday & Co Wealth Management’s Boston Scientific BSX Stock Holding History

Cassaday & Co Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$32.3K	Buy	+515	New	+$41.2K	﹤0.01%	701

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cassaday & Co Wealth Management's BSX Position: Q1 2026 in Review

Cassaday & Co Wealth Management opened a new position in Boston Scientific (BSX) in Q1 2026: 515 shares worth $32.3K. The stake represents ﹤0.01% of the portfolio and ranks #701 among its holdings.

1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Cassaday & Co Wealth Management held 515 shares of Boston Scientific worth $32.3K as of Q1 2026.
Boston Scientific was a new Cassaday & Co Wealth Management position in Q1 2026.
Boston Scientific made up ﹤0.01% of Cassaday & Co Wealth Management's portfolio in Q1 2026, its #701 holding.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Cassaday & Co Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.